GlassScriptPhysician profile
Kenneth S Campbell
NPI 1386694222
$5,721.25
in general payments reported to CMS, 2019-2025
25 companies · $472 in 2025
The $472 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $896 · 2020: $318 · 2021: $208 · 2022: $744 · 2023: $463 · 2024: $2,620 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,892 · Travel and Lodging: $1,663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,892.16 |
| Travel and Lodging | $1,662.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $1,482.51 | 2022-2025 | |
| Lifenet Health | $978.24 | 2024-2025 | Theragenesis Wound Matrix |
| Organogenesis INC. | $705.22 | 2019-2025 | Puraply, Apligraf, Affinity |
| Smith+Nephew, INC. | $584.68 | 2019-2025 | Collagenase Santyl, Versajet, Grafix Pl |
| Melinta Therapeutics, LLC | $410.59 | 2021-2024 | Kimyrsa, Orbactiv |
| Paratek Pharmaceuticals, INC. | $361.27 | 2019-2024 | Nuzyra |
| Kci USA, INC. | $155.75 | 2019-2022 | |
| Aroa Biosurgery Incorporated | $138.98 | 2019-2020 | |
| Osiris Therapeutics INC. | $114.65 | 2019 | |
| Allergan, INC. | $100.00 | 2020 | |
| Boston Scientific Corporation | $82.74 | 2019 | |
| Novo Nordisk As | $82.05 | 2023 | |
| Urgo Medical North America, LLC | $71.12 | 2023-2024 | Urgoclean Ag, Urgok2 |
| Ovik Health, LLC | $66.83 | 2019-2022 | |
| Kerecis Limited | $58.52 | 2021-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $53.75 | 2020-2021 | |
| Integra Lifesciences Corporation | $46.09 | 2019-2022 | |
| Bioventus LLC | $37.54 | 2022 | |
| Advanced Oxygen Therapy INC. | $32.74 | 2022-2024 | Topical Oxygen Chamber For Extremities |
| Cashflow Solutions, LLC | $31.93 | 2024-2025 | Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White |
| Reprise Biomedical, INC. | $29.68 | 2024-2025 | Miro3d, Miro 3d |
| Tactile Systems Technology INC | $28.41 | 2019-2025 | Nimbl, Flexitouch Plus |
| Musculoskeletal Transplant Foundation INC. | $25.87 | 2019-2021 | |
| Molnlycke Health Care US, LLC | $23.79 | 2023 | Mepilex Border Flex, Exufiber Ag+, Exufiber |
| Solventum Corporation | $18.30 | 2025 | Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.